https://www.selleckchem.com/pr....oducts/ci994-tacedin
Background Cross-sectional studies suggest an exacerbation-prone asthma (EPA) phenotype and the utility of blood eosinophils and plasma interleukin 6 (IL-6) as predictive biomarkers. Objective To prospectively test for EPA phenotype and utility of baseline blood measures of eosinophils and IL6 as predictive biomarkers. Methods Three-year asthma exacerbation data were analyzed in 406 adults in the Severe Asthma Research Program-3. Transition models were used to assess uninformed and informed probabilities of exacerbation in ye
Like
Comment
Share
